$22M NIH award will accelerate 'CRISPR' research at UC Berkeley, Ohio State

The National Institutes of Health (NIH) is incentivizing researchers to think beyond single applications of genome editing and to develop platform approaches that can be used to address multiple diseases.

Related Keywords

Ohio ,United States ,Emmanuelle Charpentier ,Krystof Bankiewicz ,Jerusha Naidoo ,Ross Wilson ,Jennifer Doudna ,Victor Van Laar ,Petros Giannikopoulos ,Russell Lonser ,Fyodor Urnov ,Claire Clelland ,Niren Murthy ,Innovative Genomics Institute ,Ohio State Gene Therapy Institute ,National Institutes Of Health ,Ohio State University Wexner Medical Center ,College Of Medicine ,Ohio State Department Of Neurological Surgery ,National Institutes ,Cell Genome Editing ,Neurological Disease ,Allele Specific Excision ,Investigational New Drug ,Ohio State ,Ohio State Department ,Gene Therapy Institute ,